Indofarma Tbk PT


Indofarma Tbk PT

Health CarePharmaceuticals and Biotechnology
  • Price (IDR)600.00
  • Today's Change0.00 / 0.00%
  • Shares traded69.90k
  • 1 Year change-46.43%
  • Beta-0.6173
Data delayed at least 10 minutes, as of Jun 05 2023 09:45 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Events & Activity

  • INAF:JKT price moved over -1.64% to 600.00

Key statistics

On Monday, Indofarma Tbk PT (INAF:JKT) closed at 600.00, 3.45% above its 52-week low of 580.00, set on May 30, 2023.
52-week range
580.00May 30 20231,350.00Jul 13 2022
Previous close600.00
Average volume67.66k
Shares outstanding3.10bn
Free float599.27m
P/E (TTM)--
Market cap1.86tn IDR
EPS (TTM)-141.68
Data delayed at least 10 minutes, as of Jun 05 2023 09:45 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.